166 related articles for article (PubMed ID: 29880707)
1. GENETICS IN ENDOCRINOLOGY: Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risks.
Persani L; de Filippis T; Colombo C; Gentilini D
Eur J Endocrinol; 2018 Sep; 179(3):R111-R123. PubMed ID: 29880707
[TBL] [Abstract][Full Text] [Related]
2. Next generation sequencing in endocrine practice.
Forlenza GP; Calhoun A; Beckman KB; Halvorsen T; Hamdoun E; Zierhut H; Sarafoglou K; Polgreen LE; Miller BS; Nathan B; Petryk A
Mol Genet Metab; 2015; 115(2-3):61-71. PubMed ID: 25958132
[TBL] [Abstract][Full Text] [Related]
3. Search for Novel Mutational Targets in Human Endocrine Diseases.
Park SY; Seo MH; Lee S
Endocrinol Metab (Seoul); 2019 Mar; 34(1):23-28. PubMed ID: 30912335
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing in neonatology: what does it mean for the next generation?
Janvier A; Barrington K; Lantos J
Hum Genet; 2022 May; 141(5):1027-1034. PubMed ID: 35348890
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
6. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
[TBL] [Abstract][Full Text] [Related]
7. Next generation sequencing applications for cardiovascular disease.
Kalayinia S; Goodarzynejad H; Maleki M; Mahdieh N
Ann Med; 2018 Mar; 50(2):91-109. PubMed ID: 29027470
[TBL] [Abstract][Full Text] [Related]
8. Insights from exome sequencing for endocrine disorders.
de Bruin C; Dauber A
Nat Rev Endocrinol; 2015 Aug; 11(8):455-64. PubMed ID: 25963271
[TBL] [Abstract][Full Text] [Related]
9. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
Linthorst GE; Hollak CEM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
[TBL] [Abstract][Full Text] [Related]
10. Next-generation diagnostics: gene panel, exome, or whole genome?
Sun Y; Ruivenkamp CA; Hoffer MJ; Vrijenhoek T; Kriek M; van Asperen CJ; den Dunnen JT; Santen GW
Hum Mutat; 2015 Jun; 36(6):648-55. PubMed ID: 25772376
[TBL] [Abstract][Full Text] [Related]
11. Free-access copy-number variant detection tools for targeted next-generation sequencing data.
Roca I; González-Castro L; Fernández H; Couce ML; Fernández-Marmiesse A
Mutat Res Rev Mutat Res; 2019; 779():114-125. PubMed ID: 31097148
[TBL] [Abstract][Full Text] [Related]
12. [Novel methods and their applicability in the evaluation of the genetic background of endocrine system tumours].
Patócs A; Likó I; Butz H; Baghy K; Rácz K
Orv Hetil; 2015 Dec; 156(51):2063-9. PubMed ID: 26654542
[TBL] [Abstract][Full Text] [Related]
13. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease.
Ali H; Al-Mulla F; Hussain N; Naim M; Asbeutah AM; AlSahow A; Abu-Farha M; Abubaker J; Al Madhoun A; Ahmad S; Harris PC
Sci Rep; 2019 Mar; 9(1):4141. PubMed ID: 30858458
[TBL] [Abstract][Full Text] [Related]
14. JWES: a new pipeline for whole genome/exome sequence data processing, management, and gene-variant discovery, annotation, prediction, and genotyping.
Ahmed Z; Renart EG; Mishra D; Zeeshan S
FEBS Open Bio; 2021 Sep; 11(9):2441-2452. PubMed ID: 34370400
[TBL] [Abstract][Full Text] [Related]
15. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
[TBL] [Abstract][Full Text] [Related]
17. Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
van Nimwegen KJ; van Soest RA; Veltman JA; Nelen MR; van der Wilt GJ; Vissers LE; Grutters JP
Clin Chem; 2016 Nov; 62(11):1458-1464. PubMed ID: 27630156
[TBL] [Abstract][Full Text] [Related]
18. [UTILIZATION OF WHOLE EXOME SEQUENCING IN DIAGNOSTICS OF GENETIC DISEASE: RABIN MEDICAL CENTER'S EXPERIENCE].
Cohen L; Orenstein N; Weisz-Hubshman M; Bazak L; Davidov B; Reinstein E; Tzur S; Behar D; Smirin-Yosef P; Salmon-Divon M; Gross A; Shohat M; Basel-Vanagaite L
Harefuah; 2017 Apr; 156(4):212-216. PubMed ID: 28551919
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic yield of next-generation sequencing in 87 families with neurodevelopmental disorders.
Álvarez-Mora MI; Sánchez A; Rodríguez-Revenga L; Corominas J; Rabionet R; Puig S; Madrigal I
Orphanet J Rare Dis; 2022 Feb; 17(1):60. PubMed ID: 35183220
[TBL] [Abstract][Full Text] [Related]
20. Next-generation sequencing: ready for the clinics?
Desai AN; Jere A
Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
